- Home
- EOD vs CADL Comparison
EOD vs CADL Comparison
Compare EOD & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EOD
- CADL
- Stock Information
- Founded
- EOD 2007
- CADL 1999
- Country
- EOD United States
- CADL United States
- Employees
- EOD N/A
- CADL N/A
- Industry
- EOD Investment Managers
- CADL Biotechnology: Pharmaceutical Preparations
- Sector
- EOD Finance
- CADL Health Care
- Exchange
- EOD Nasdaq
- CADL Nasdaq
- Market Cap
- EOD 213.8M
- CADL 234.8M
- IPO Year
- EOD N/A
- CADL 2021
- Fundamental
- Price
- EOD $5.29
- CADL $5.75
- Analyst Decision
- EOD
- CADL Strong Buy
- Analyst Count
- EOD 0
- CADL 4
- Target Price
- EOD N/A
- CADL $21.00
- AVG Volume (30 Days)
- EOD 118.1K
- CADL 964.3K
- Earning Date
- EOD 01-01-0001
- CADL 05-13-2025
- Dividend Yield
- EOD 9.28%
- CADL N/A
- EPS Growth
- EOD N/A
- CADL N/A
- EPS
- EOD N/A
- CADL N/A
- Revenue
- EOD N/A
- CADL N/A
- Revenue This Year
- EOD N/A
- CADL N/A
- Revenue Next Year
- EOD N/A
- CADL N/A
- P/E Ratio
- EOD N/A
- CADL N/A
- Revenue Growth
- EOD N/A
- CADL N/A
- 52 Week Low
- EOD $3.73
- CADL $3.79
- 52 Week High
- EOD $4.71
- CADL $14.60
- Technical
- Relative Strength Index (RSI)
- EOD 61.72
- CADL 55.12
- Support Level
- EOD $5.16
- CADL $5.18
- Resistance Level
- EOD $5.30
- CADL $6.29
- Average True Range (ATR)
- EOD 0.07
- CADL 0.41
- MACD
- EOD -0.00
- CADL 0.06
- Stochastic Oscillator
- EOD 93.75
- CADL 57.19
About EOD Allspring Global Dividend Opportunity Fund of Beneficial Interest
Allspring Global Dividend Opportunity Fund is a diversified closed-end management investment company. Its primary investment objective is to seek a high level of current income. The fund's secondary objective is the long-term growth of capital. The fund allocates its assets between two separate investment strategies or sleeves. Under normal market conditions, the fund allocates approximately 80% of its total assets to an equity sleeve comprised of common stocks.
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.